Vitae https://revistas.udea.edu.co/index.php/vitae <ul> <li class="show"><span style="font-family: Avenir;"><strong>ISSN Impreso:</strong> 0121-4004</span></li> <li class="show"><span style="font-family: Avenir;"><strong>ISSN electrónico: </strong>2145-2660</span></li> <li class="show"><span style="font-family: Avenir;"><strong>Periodicidad:</strong> cuatrimestral</span></li> <li class="show"><span style="font-family: Avenir;"><strong>Creative Commons:</strong> <a href="https://creativecommons.org/licenses/by-nc-sa/2.5/co/" target="_blank" rel="noopener">by-nc-sa</a></span></li> </ul> en-US <h1>Copyright Notice and Open Access Statement</h1> <p align="justify"><span style="font-family: Avenir;">The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/" target="_blank" rel="noopener"><u>Creative Commons license</u></a>, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.</span></p> <h3><span style="font-family: Avenir;">Authors declare that:</span></h3> <ol> <li value="1"> <p align="justify"><span style="font-family: Avenir;">They are the intellectual property owners and are responsible for all the information stated in the article.</span></p> </li> <li value="2"> <p align="justify"><span style="font-family: Avenir;">This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.</span></p> </li> <li value="3"> <p align="justify"><span style="font-family: Avenir;">They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.</span></p> </li> <li value="4"> <p align="justify"><span style="font-family: Avenir;">They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.</span></p> </li> <li value="5"> <p align="justify"><span style="font-family: Avenir;">Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.</span></p> </li> <li value="6"> <p align="justify"><span style="font-family: Avenir;">They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.</span></p> </li> <li value="7"> <p align="justify"><span style="font-family: Avenir;">They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.</span></p> </li> <li value="8"> <p align="justify"><span style="font-family: Avenir;">They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.</span></p> </li> <li value="9"> <p align="justify"><span style="font-family: Avenir;">After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.</span></p> </li> </ol> <p align="justify"><span style="font-family: Avenir;"><strong>Conflict of interest:</strong> Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.</span></p> revistavitae@udea.edu.co (Editor) revistavitae@udea.edu.co (Editor) Tue, 04 Mar 2025 11:11:39 -0500 OJS 3.3.0.13 http://blogs.law.harvard.edu/tech/rss 60 Inhibition of a Myotoxic Phospholipase A2 isolated from Crotalus durissus cumanensis by Pentacyclic Triterpenes https://revistas.udea.edu.co/index.php/vitae/article/view/356555 <p style="font-weight: 400;"><strong>BACKGROUND:</strong> Ophidian accidents have been recognized as public health events in Colombia since 2004 and have been systematically reported since 2007, constituting a significant public health problem. One of the components present in the venoms of Viperidae snakes is the phospholipase A<sub>2</sub> (PLA<sub>2</sub>) enzyme, playing a fundamental role in snakebite poisoning and responsible for many of the local effects that are not neutralized by antivenoms, the only treatment approved for the management of these accidents. Traditional herbal treatments hold promise, with ethnopharmacological studies emphasizing compounds, particularly pentacyclic triterpenes, as potential inhibitors of PLA<sub>2</sub>. <br /><strong>OBJECTIVE:</strong><strong> </strong>To identify compounds with the potential to reduce or neutralize the local effects generated by PLA<sub>2</sub>, present in the venom of snakes of the Viperidae family, the major cause of ophidian accidents in Colombia. <br /><strong>METHODS:</strong> Four triterpenic compounds (madecassic acid, ursolic acid, betulinic acid, and oleanolic acid) were evaluated to determine the inhibitory capacity on the enzymatic activity of myotoxic phospholipase A<sub>2</sub>, extracted from <em>Crotalus durissus cumanensis</em> venom and purified by RP-HPLC. To determine the inhibitory capacity of the compounds against the enzymatic activity of PLA<sub>2</sub>, the synthetic monodisperse substrate 4-nitro-3- (octanoloxy) benzoic acid was used. Molecular docking was also performed to identify by visual inspection the interactions between the compounds and the active site of the enzyme. <br /><strong>RESULTS:</strong> The highest percentage of inhibition was presented by ursolic acid (47.01%). This is supported by the results of the molecular docking, where this compound was found to have interactions with Leu2, Phe24, Tyr52, and Lys69, amino acids involved in the catalytic activity of the enzyme. <br /><strong>CONCLUSIONS</strong>: Ursolic acid was determined as the most promising compound among the four evaluated against the local effects generated by PLA<sub>2</sub>. Future studies may be performed to determine other potential benefits of these compounds versus other biological actions of the enzyme.</p> Laura Cardona-Alzate, Lina Maria Preciado-Rojo, Isabela Barahona-Sanchez, Vanesa Cardona-Cartagena, Jaime Andres Pereañez Copyright (c) 2025 Laura Cardona-Alzate, Lina Maria Preciado-Rojo, Isabela Barahona-Sanchez, Vanesa Cardona-Cartagena, Jaime Andres Pereañez https://creativecommons.org/licenses/by-nc-sa/4.0 https://revistas.udea.edu.co/index.php/vitae/article/view/356555 Tue, 04 Mar 2025 00:00:00 -0500 Phoradendron bathyoryctum Eichler relieves acute nociceptive pain stimulus and carrageenan-induced inflammation in mice https://revistas.udea.edu.co/index.php/vitae/article/view/356558 <p style="font-weight: 400;"><strong>Background:</strong> The genus <em>Phoradendron</em> belongs to the Santalaceae family and possesses several species with antitumor, cytotoxic, and immunomodulatory activity, where pain and inflammation are common symptoms. It is used in venereal and liver diseases in Paraguayan folk medicine. In addition, it claims to have tonic properties for the heart and central nervous system. Previous studies have shown that crude extract of <em>Phoradendron bathyoryctum</em> Eichler (<em>Pb</em>) has anxiolytic and antidepressant activity.<br /><strong>Objective:</strong> This work aimed to determine the anti-nociceptive and anti-inflammatory activity of<em>Pb</em> using acute models in mice.<br /><strong>Methods:</strong> the anti-nociceptive activity of <em>Pb</em> was evaluated using mechanical pressure (Randall-Selitto test), acetic acid (writhing test), and heat (hot plate test) noxious stimulus in mice. The anti-inflammatory activity was assessed through carrageenan-induced plantar edema in mice previously treated with <em>Pb</em>.<br /><strong>Results:</strong> Presences of high polarity alkaloids, steroids/ free triterpenoids, leucoanthocyanidins, and tannins were detected in phytochemical studies. Oral doses of 30 (p&lt;0.01) and 300 (p&lt;0.001) mg/kg of <em>Pb</em> denoted a significant dose-dependent increase in pain threshold, using the Randall-Selitto and Writhing test (30; p&lt;0.05; and 300; p&lt;0.01. In addition, consistent with the above anti-nociceptive effect, an increase in the reaction latency time after oral administration of <em>Pb</em> at a dose of 300 mg/kg (p&lt;0.05) in the hot plate test was denoted. Finally, a significant reduction of edema (30 mg/kg; p&lt;0.01) induced by 1% carrageenan was evidenced, demonstrating a potential anti-inflammatory activity of <em>Pb</em> compared to the positive edema control. Interestingly, the anti-edematous activity of <em>Pb</em> showed a similar intensity response compared to the group treated with 10 mg/kg indomethacin (p&lt;0.01).<br /><strong>Conclusion:</strong> This work revealed that the crude extract of <em>Pb</em> can increase pain threshold, be compatible with an analgesic effect, and reduce edema (anti-inflammatory) induced by Carrageenan in mice. Further pharmacological and chemical studies are being conducted to elucidate molecular mechanisms and components involved in the observed effects.</p> Mariela Ortiz Rivas, Olga Heinichen, Wilfrido Arrua, Rosa Degen de Arrua, Derlis A. Ibarrola D., Maria del Carmen Hellion-Ibarrola Copyright (c) 2025 Mariela Ortiz Rivas, Olga Heinichen, Wilfrido Arrua, Rosa Degen de Arrua, Derlis A. Ibarrola D., Maria del Carmen Hellion-Ibarrola https://creativecommons.org/licenses/by-nc-sa/4.0 https://revistas.udea.edu.co/index.php/vitae/article/view/356558 Tue, 04 Mar 2025 00:00:00 -0500